Clinical Trial Investigates Multicolor Tattoo Removal in Fewer Treatments

Share Article

Study published in Lasers in Surgery and Medicine, the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS), found that the new titanium sapphire laser handpiece is more effective on clearing green, blue, and purple tattoo pigments.

Eric F. Bernstein, MD, MSE

A commercial 785 nm Ti-Sapphire laser has been a long time coming. Having a picosecond-domain version for treating blue, green and purple tattoos is a big advantage.

The first ever production picosecond‐domain laser with a 785 nm wavelength was recently developed to improve the rate of clearance of green, blue, and purple tattoo inks - often the colors most resistant to laser removal.

A clinical trial published in Lasers in Surgery and Medicine (LSM), the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS) investigated the safety and efficacy of the new 785 nm Ti-Sapphire laser for treating blue, green and purple tattoo inks as an addition to a picosecond-domain 1,064 nm and 532 nm laser platform. This first study of a new, 785 nm, picosecond-domain, laser-pumped-laser demonstrates safe and effective removal of multicolor tattoos.

The study, conducted by Eric F. Bernstein, MD; Jayant Bhawalkar, PhD; and Kevin T. Schomacker, PhD, titled “A Novel Titanium Sapphire Picosecond-domain Laser Safely and Effectively Removes Purple, Blue and Green Tattoo Inks,” was selected as Editor’s Choice in the September 2018 issue of LSM.

“The laser-pumped-laser concept enables delivery of multiple discrete wavelengths from a single laser platform. A commercial 785 nm Ti-Sapphire laser has been a long time coming,” said Dr. Bernstein. “Having a picosecond-domain version for treating blue, green and purple tattoos is a big advantage.”

Eric F. Bernstein, MD, MSE received his BS from Duke University, and his MD from the Yale University School of Medicine, and an MSE in Management of Technology from the Engineering School at University of Pennsylvania, co-administered by the Wharton School. Following fellowships with the NCI at the NIH and Hahnemann University, he joined Jefferson Medical College, where he directed a photobiology laboratory and served as director of the Laser Surgery Center. Dr. Bernstein holds numerous and international patents, has authored over 100 scientific publications, and has given more than 300 presentations worldwide.

Dr. Bernstein currently directs Main Line Center for Laser Surgery, an aesthetic laser practice in Ardmore, Pennsylvania, and serves as a president of the ASLMS, the premier, global society focusing on the use of energy-based devices in medicine. Dr. Bernstein’s practice focuses heavily on studies of new lasers for FDA-clearance, and he actively participates in several start-ups.

Editor’s Choice is an exclusive article published in LSM, the official journal of the ASLMS. View the complete manuscript.

Share article on social media or email:

View article via:

Pdf Print